ZANTE GREG (Chief Financial Officer) sold 2.5% of their position (4.27K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $118.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/3/2025ACC: 0000950170-25-093792
Officer· Chief Financial Officer
Since Jan 2021
+3.40K
Net shares
Net buyer
$118.4K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
7.67K acquired · 4.27K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+7.67K
Price / share
—
Trade value
—
% of position
4.6%
7/2/2025
165.26K→172.93K
Common Stock, par value $0.00001 per share
Direct
Shares
−4.27K
Price / share
$27.76
Trade value
$118.43K
% of position
2.5%
7/3/2025
172.93K→168.66K
Total
Net shares
+3.40K
Net value
-$118.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 7/2/2025 | A · Award | +7.67K | — | — | 4.6% | 165.26K | 172.93K |
| Common Stock, par value $0.00001 per share Direct | 7/3/2025 | S · Sale | −4.27K | $27.76 | $118.43K | 2.5% | 172.93K | 168.66K |
| Total | +3.40K | -$118.43K | ||||||
Derivative Transactions0
No derivative transactions reported